SCHEMBL4769334

SCHEMBL4769334

CCCCONC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7004298 0.91
SCHEMBL9816113 0.88 EPHX1 (0.46)
SCHEMBL15283021 0.88 EPHX1 (0.46)
SCHEMBL13745905 0.88 EPHX1 (0.46)
SCHEMBL15282804 0.88 EPHX1 (0.46)
SCHEMBL6729067 0.88
SCHEMBL15283192 0.88 EPHX1 (0.46)
Bromide SCHEMBL29006840 0.86 EPHX1 (0.45)
SCHEMBL2606460 0.80
SCHEMBL2340182 0.78 ADRB2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9399735-B2 Mannich-base inhibitor for decalcification, preparation method and application thereof PETROCHINA COMPANY LIMITED (CN) 2016-07-26 US claimed
US-20130256602-A1 MANNICH-BASE INHIBITOR FOR DECALCIFICATION, PREPARATION METHOD AND APPLICATION THEREOF PETROCHINA COMPANY LIMITED (CN) 2013-10-03 US claimed
US-20230340011-A1 STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS Asteroid Therapeutics 2023-10-26 US disclosed
US-20230340011-A1 STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS Asteroid Therapeutics 2023-10-26 US disclosed
CN-110831997-B Mixtures of radically curable compounds and their use 喜利得股份公司 2022-02-22 CN disclosed
EP-3892272-A1 BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE Dana-Farber Cancer Institute, Inc. (US) 2021-10-13 EP disclosed
EP-3307258-B1 ARYL SULFONOHYDRAZIDES UNIV MONASH (AU) 2020-12-16 EP disclosed
CN-105452398-B Composition for ink, ink jet recording method and tingle body using this composition for ink 日本化药株式会社 2018-07-10 CN disclosed
EP-2770977-B1 NOVEL DOSAGE FORM NEUROVIVE PHARMACEUTICAL AB (SE) 2017-07-12 EP disclosed
US-9504728-B2 Dosage form NEUROVIVE PHARMACEUTICAL AB (SE) 2016-11-29 US disclosed
US-9504728-B2 Dosage form NEUROVIVE PHARMACEUTICAL AB (SE) 2016-11-29 US disclosed
US-4863954-A Acyloxythiophene-carboxamide fungicides BAYER AKTIENGESELLSCHAFT (DE) 1989-09-05 US disclosed
EP-0207355-B1 ALKOXYCARBONYL-SUBSTITUTED HYDROXYTHIOPHENE CARBOXAMIDES BAYER AG (DE) 1988-10-19 EP disclosed
US-4767757-A Acyloxythiophene-carboxamide fungicides, compositions and use BAYER AKTIENGESELLSCHAFT (DE) 1988-08-30 US disclosed
US-4752607-A Alkoxycarbonyl-substituted hydroxythiophene-carboxamides, fungicidal compositions and use BAYER AKTIENGESELLSCHAFT (DE) 1988-06-21 US disclosed
EP-0260827-A2 Coating compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-03-23 EP disclosed
EP-0241735-A2 Acyloxythiophene carbon amide BAYER AG (DE) 1987-10-21 EP disclosed
EP-0207355-A1 Alkoxycarbonyl-substituted hydroxythiophene carboxamides BAYER AG (DE) 1987-01-07 EP disclosed
US-4322271-A ETHERIFICATION OF AN N-ETHYL AMIDE BY ANODIZING WITH AN ALCOHOL; ALKYLATION; DEETHERIFICATION HOECHST AKTIENGESELLSCHAFT (DE) 1982-03-30 US disclosed
US-4288300-A IN ELECTROLYTIC CELL HAVING ALKALI METAL OR TETRAALKYLAMMONIUM ALKOSULFATE AS ELECTROLYTE HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-08 US disclosed